Th1 cytokine interferon gamma improves response in HER2 breast cancer by modulating the ubiquitin proteasomal pathwayYongsheng Jia, Brian J. Czerniecki, Shari Pilon‐Thomas et al.|Molecular Therapy|2021Cited by 56
Intratumoral delivery of dendritic cells plus anti-HER2 therapy triggers both robust systemic antitumor immunity and complete regression in HER2 mammary carcinomaGanesan Ramamoorthi, Brian J. Czerniecki, Krithika N. Kodumudi et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 26
Challenges in Detection of Serum Oncoprotein: Relevance to Breast Cancer DiagnosticsJustin Lengfeld, Payal Grover, Hongtao Zhang et al.|Breast Cancer Targets and Therapy|2021Cited by 10